The higher risk of metastases associated with higher Gleason grade, PSA velocity, and characteristics on multiparametric magnetic resonance imaging [3] and genomic alterations in aggressive prostate cancer manifested early, many years before the metastatic disease was detected clinically [4]. This evidence concerns the gene KLK3 and prostate cancer.